Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level

Hyperprolactinemia is a common side effect of antipsychotic drugs. Although changes of antipsychotic drugs or reduction of their doses can solve this problem, a modification of the treatment regimen can lead to instability in patients. Herein, we followed up a patient with elevated prolactin caused...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhi, Pu, Wang, Yanqiong, Quan, Wei, Su, Yanli, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120516/
https://www.ncbi.nlm.nih.gov/pubmed/30214207
http://dx.doi.org/10.2147/NDT.S167129
_version_ 1783352287271321600
author Zhi, Pu
Wang, Yanqiong
Quan, Wei
Su, Yanli
Zhang, Hui
author_facet Zhi, Pu
Wang, Yanqiong
Quan, Wei
Su, Yanli
Zhang, Hui
author_sort Zhi, Pu
collection PubMed
description Hyperprolactinemia is a common side effect of antipsychotic drugs. Although changes of antipsychotic drugs or reduction of their doses can solve this problem, a modification of the treatment regimen can lead to instability in patients. Herein, we followed up a patient with elevated prolactin caused by paliperidone and found that the prolactin level was decreased after the administration of a combination with a low-dose aripiprazole. In addition, we summarized and analyzed the findings from the case and the literature review conducted.
format Online
Article
Text
id pubmed-6120516
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61205162018-09-13 Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level Zhi, Pu Wang, Yanqiong Quan, Wei Su, Yanli Zhang, Hui Neuropsychiatr Dis Treat Case Report Hyperprolactinemia is a common side effect of antipsychotic drugs. Although changes of antipsychotic drugs or reduction of their doses can solve this problem, a modification of the treatment regimen can lead to instability in patients. Herein, we followed up a patient with elevated prolactin caused by paliperidone and found that the prolactin level was decreased after the administration of a combination with a low-dose aripiprazole. In addition, we summarized and analyzed the findings from the case and the literature review conducted. Dove Medical Press 2018-08-27 /pmc/articles/PMC6120516/ /pubmed/30214207 http://dx.doi.org/10.2147/NDT.S167129 Text en © 2018 Zhi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Report
Zhi, Pu
Wang, Yanqiong
Quan, Wei
Su, Yanli
Zhang, Hui
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
title Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
title_full Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
title_fullStr Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
title_full_unstemmed Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
title_short Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
title_sort aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120516/
https://www.ncbi.nlm.nih.gov/pubmed/30214207
http://dx.doi.org/10.2147/NDT.S167129
work_keys_str_mv AT zhipu aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel
AT wangyanqiong aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel
AT quanwei aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel
AT suyanli aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel
AT zhanghui aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel

Ejemplares similares